Above expectations: Consolidated net sales, adjusted EBITDA and adjusted PAT grew 7.8% (comparable), 16% and 19% (vs. consensus estimates of 8%, 13% and 10%). Revenue growth was aided by mid-single digit volume growth. Gross margin improved 67 bps YoY but flat QoQ at 37.6% on benign input cost. EBIT